These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 14531724)

  • 1. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.
    Stalker DJ; Jungbluth GL
    Clin Pharmacokinet; 2003; 42(13):1129-40. PubMed ID: 14531724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
    Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
    J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.
    MacGowan AP
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii17-25. PubMed ID: 12730139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries.
    Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C
    J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of pharmacokinetic and pharmacodynamic aspects of linezolid with infection outcome.
    Vardakas KZ; Kioumis I; Falagas ME
    Curr Drug Metab; 2009 Jan; 10(1):2-12. PubMed ID: 19149508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr.
    Hendershot PE; Antal EJ; Welshman IR; Batts DH; Hopkins NK
    J Clin Pharmacol; 2001 May; 41(5):563-72. PubMed ID: 11361053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid absolute bioavailability and the effect of food on oral bioavailability.
    Welshman IR; Sisson TA; Jungbluth GL; Stalker DJ; Hopkins NK
    Biopharm Drug Dispos; 2001 Apr; 22(3):91-7. PubMed ID: 11745911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid: the first oxazolidinone antimicrobial.
    Moellering RC
    Ann Intern Med; 2003 Jan; 138(2):135-42. PubMed ID: 12529096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid pharmacokinetics in pediatric patients: an overview.
    Jungbluth GL; Welshman IR; Hopkins NK
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single dose pharmacokinetics of linezolid in infants and children.
    Kearns GL; Abdel-Rahman SM; Blumer JL; Reed MD; James LP; Jacobs RF; Bradley JA; Welshman IR; Jungbluth GL; Stalker DJ;
    Pediatr Infect Dis J; 2000 Dec; 19(12):1178-84. PubMed ID: 11144380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.
    Slatter JG; Stalker DJ; Feenstra KL; Welshman IR; Bruss JB; Sams JP; Johnson MG; Sanders PE; Hauer MJ; Fagerness PE; Stryd RP; Peng GW; Shobe EM
    Drug Metab Dispos; 2001 Aug; 29(8):1136-45. PubMed ID: 11454733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E.
    Gordi T; Tan LH; Hong C; Hopkins NJ; Francom SF; Slatter JG; Antal EJ
    J Clin Pharmacol; 2003 Oct; 43(10):1161-7. PubMed ID: 14517199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of linezolid in subjects with renal dysfunction.
    Brier ME; Stalker DJ; Aronoff GR; Batts DH; Ryan KK; O'Grady M; Hopkins NK; Jungbluth GL
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2775-80. PubMed ID: 12936973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid: in infants and children with severe Gram-positive infections.
    Lyseng-Williamson KA; Goa KL
    Paediatr Drugs; 2003; 5(6):419-29; discussion 430-1. PubMed ID: 12765493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic evaluation of concomitant administration of linezolid and aztreonam.
    Sisson TL; Jungbluth GL; Hopkins NK
    J Clin Pharmacol; 1999 Dec; 39(12):1277-82. PubMed ID: 10586394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients.
    El-Assal MI; Helmy SA
    Biopharm Drug Dispos; 2014 Oct; 35(7):405-16. PubMed ID: 25044219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients.
    Plock N; Buerger C; Joukhadar C; Kljucar S; Kloft C
    Drug Metab Dispos; 2007 Oct; 35(10):1816-23. PubMed ID: 17639029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.
    Nukui Y; Hatakeyama S; Okamoto K; Yamamoto T; Hisaka A; Suzuki H; Yata N; Yotsuyanagi H; Moriya K
    J Antimicrob Chemother; 2013 Sep; 68(9):2128-33. PubMed ID: 23625638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid for the treatment of resistant gram-positive cocci.
    Bain KT; Wittbrodt ET
    Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of linezolid in patients treated in a compassionate-use program.
    Meagher AK; Forrest A; Rayner CR; Birmingham MC; Schentag JJ
    Antimicrob Agents Chemother; 2003 Feb; 47(2):548-53. PubMed ID: 12543657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.